- Q4 2023 WAVE Life Sciences Ltd Earnings Call TranscriptMar 06, 2024$6.29 (+31.32%)Earnings
- WAVE Life Sciences Ltd at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 WAVE Life Sciences Ltd Earnings Call TranscriptNov 09, 2023$5.21 (-9.55%)Earnings
- WAVE Life Sciences Ltd R&D Day TranscriptSep 28, 2023
- Q2 2023 WAVE Life Sciences Ltd Earnings Call TranscriptAug 03, 2023$5.06 (+15.79%)Earnings
- WAVE Life Sciences Ltd FOCUS-C9 Clinical Trial Results Conference Call TranscriptMay 23, 2023
- Q1 2023 WAVE Life Sciences Ltd Earnings Call TranscriptMay 03, 2023$3.75 (+1.90%)Earnings
- Q4 2022 WAVE Life Sciences Ltd Earnings Call TranscriptMar 22, 2023$3.8 (-10.38%)Earnings
- WAVE Life Sciences Ltd WVE-N531 Clinical Trial Update Call TranscriptDec 19, 2022
- WAVE Life Sciences Ltd Business Update TranscriptDec 13, 2022
- Q3 2022 WAVE Life Sciences Ltd Earnings Call TranscriptNov 10, 2022$4.17 (+5.84%)Earnings
- WAVE Life Sciences Ltd Investor Event TranscriptSep 28, 2022
- WAVE Life Sciences Ltd SELECT-HD Clinical Trial Update TranscriptSep 20, 2022
- Q2 2022 WAVE Life Sciences Ltd Earnings Call TranscriptAug 11, 2022$2.98 (+16.86%)Earnings
- WAVE Life Sciences Ltd at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2022
- Q1 2022 WAVE Life Sciences Ltd Earnings Call TranscriptMay 12, 2022$1.29 (-12.24%)Earnings
- WAVE Life Sciences Ltd Genetic Medicines and Cell Therapy Manufacturing Summit TranscriptApr 26, 2022
- WAVE Life Sciences Ltd to Discuss the FOCUS-C9 Clinical Trial Update Investor Call TranscriptApr 04, 2022
- WAVE Life Sciences Ltd at Stifel CNS Days (Virtual) TranscriptMar 28, 2022
- Q4 2021 WAVE Life Sciences Ltd Earnings Call TranscriptMar 03, 2022$2.39 (-2.85%)Earnings
- Q3 2021 WAVE Life Sciences Ltd Earnings Call TranscriptNov 10, 2021$4.69 (+0.43%)Earnings
- WAVE Life Sciences Ltd Analyst And Investor Research Corporate Call TranscriptSep 28, 2021
- Q2 2021 WAVE Life Sciences Ltd Earnings Call TranscriptAug 05, 2021$6.03 (+8.65%)Earnings
- Q1 2021 WAVE Life Sciences Ltd Earnings Call TranscriptMay 13, 2021$5.86 (-4.25%)Earnings
- WAVE Life Sciences Ltd PRECISION-HD Trial Results and Business Update Call TranscriptMar 29, 2021
- Q4 2020 WAVE Life Sciences Ltd Earnings Call TranscriptMar 04, 2021$9.34 (-8.79%)Earnings
- WAVE Life Sciences Ltd at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 25, 2021
- WAVE Life Sciences Ltd at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 11, 2020
- Q3 2020 WAVE Life Sciences Ltd Earnings Call TranscriptNov 09, 2020$7.48 (+3.60%)Earnings
- Wave Life Sciences Ltd. - Shareholder/Analyst Call TranscriptAug 25, 2020
- Q2 2020 WAVE Life Sciences Ltd Earnings Call TranscriptAug 10, 2020$9.43 (+3.06%)Earnings
- Q1 2020 WAVE Life Sciences Ltd Earnings Call TranscriptMay 11, 2020$10.11 (+26.85%)Earnings
- Q4 2019 WAVE Life Sciences Ltd Earnings Call TranscriptMar 02, 2020$7.93 (-6.04%)Earnings
- WAVE Life Sciences Ltd Corporate Call TranscriptDec 30, 2019
- Wave Life Sciences Ltd Suvodirsen Update Conference Call TranscriptDec 16, 2019
- WAVE Life Sciences Ltd to Host Analyst and Investor Research Day TranscriptOct 07, 2019
WAVE Life Sciences Ltd to Host Analyst and Investor Research Day Transcript
(presentation)
And first and foremost, welcome. Thank you for taking the time out of all of your day. For everyone in this room, I'm grateful. We're grateful. I know you all have busy schedules, so we appreciate you spending some time with us to learn about what's happening at Wave. To those of you who are logged on to the webcast, we appreciate you taking the time out of your day as well and we hope to have it to be a productive one.
To make it productive, we'll quickly talk about some forward-looking statements. We will be making forward-looking statements during this presentation. So again, please refer to our SEC filings for current updates.
And with that said, I know many of you are here eagerly awaiting our clinical data for duchenne muscular dystrophy, our exon 51 suvodirsen program as well as our HD program. We are too. And it's important for you all to know that we remain on track for delivering that data this year. We anticipate delivering the suvodirsen biopsy data from our ongoing open-label
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)